+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?

Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?

Bone and Joint Journal 100-B(2): 247-255

The aim of this study was to analyse a group of patients with non-metastatic Ewing's sarcoma at presentation and identify prognostic factors affecting the development of local recurrence, in order to assess the role of radiotherapy. A retrospective review of all patients with a Ewing's sarcoma treated between 1980 and 2012 was carried out. Only those treated with chemotherapy followed by surgery and/or radiotherapy were included. Patients were grouped according to site (central or limb) for further analysis of the prognostic factors. A total of 388 patients were included in the study. Of these, 60 (15%) developed local recurrence at a mean median of 27 months (sd 24, range 7 to 150) and the five-year local recurrence-free survival (5yrLRFS) was 83%. For central tumours, the size of the tumour and histological response to chemotherapy were found to be significant factors for local recurrence. For limb tumours, local recurrence was affected by intralesional and marginal resections, but not by the histological response to chemotherapy. Radiotherapy in those with a marginal resection reduced the risk of local recurrence (5yrLRFS: 96% versus 81%, p = 0.044). Local recurrence significantly affects the overall survival in patients with a Ewing's sarcoma. For those with a tumour in a limb, radiotherapy reduced the risk of local recurrence, especially in those with a marginal margin of excision, but the effect in central tumours was less clear. Radiotherapy for those who have had a wide margin of resection does not reduce the risk of local recurrence, regardless of the histological response to chemotherapy. Cite this article: Bone Joint J 2018;100-B: 247-55.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 065485296

Download citation: RISBibTeXText

PMID: 29437069

DOI: 10.1302/0301-620x.100b2.bjj-2017-0222.r1

Related references

Is postoperative radiotherapy necessary in localised standard-risk Ewing sarcoma? : The primary tumor bulk decides upon adjuvant radiotherapy after induction chemotherapy and surgery. Strahlentherapie und Onkologie 193(1): 89-90, 2017

Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). European Journal of Cancer 99: 78-85, 2018

Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence. American Journal of Otolaryngology 34(4): 320-322, 2013

Radiotherapy versus surgery in good-risk Ewing's sarcoma: An analysis of the CESS 86-data. Strahlentherapie und Onkologie 172(5): 244-248, 1996

Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy. International Journal of Radiation Oncology Biology Physics 15(3): 627-631, 1988

Treatment of Ewing's sarcoma by radiotherapy and adjuvant chemotherapy : results at 3 and 5 years. La Nouvelle Presse Medicale 9(6): 359-362, 1980

Ewing's sarcoma family tumors of the humerus: outcome of patients treated with radiotherapy, surgery or surgery and adjuvant radiotherapy. RadioTherapy and Oncology 93(2): 383-387, 2009

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. Journal of Clinical Oncology 18(1): 4-11, 2000

Problems of local recurrence in patients with Ewing's sarcoma. Osterreichische Zeitschrift für Onkologie. Austrian Journal of Oncology 4(1): 7, 1977

Altered pattern of metastasis following treatment of Ewing's sarcoma with radiotherapy and adjuvant chemotherapy. Cancer 27(5): 1051-1054, 1971

Local therapy of Ewing sarcoma: radiotherapy aspects. Klinische Padiatrie 206(4): 277-281, 1994

The role of radiotherapy in the local treatment of Ewing's sarcoma. Praxis 84(41): 1148-1151, 1995

Technique and outcome of post-mastectomy adjuvant chest wall radiotherapy-the role of tissue-equivalent bolus in reducing risk of local recurrence. British Journal of Radiology 89(1064): 20160060, 2016

Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer 109(3): 603-611, 2007

Prevention of local-regional recurrence with the addition of radiation in post-mastectomy patients at high risk for local recurrence receiving adjuvant chemotherapy. International Journal of Radiation Oncology*biology*physics 13(Supp-S1): 161-0, 1987